#9450
Strongyloïdes
ratti IgG ELISA
ELISA kit for the diagnosis of human strongyloidosis
Lot 2319S (Expiry date : 11.02.2025)
Production date : 12.06.2023
Results of quality control 1 (after
production), date: 20.06.2023
No serum blank (average) : 0.115
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.002 |
0.001 |
0.002 |
-0.001 |
0.000 |
0 |
Negative control serum
(N° 9450-06) |
0.082 |
0.086 |
0.089 |
0.092 |
0.087 |
4 |
Weak positive serum
(N° 9450-07) |
0.784 |
0.849 |
0.804 |
0.765 |
0.800 |
35 |
Positive control serum
(N° 9450-08) |
2.199 |
2.372 |
2.302 |
2.244 |
2.279 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 9450-08 |
> 1.200 |
2.279 |
Yes |
Absorbance of weak positive serum 9450-07, as % of positive
serum |
> 18 % |
35 % |
Yes |
Absorbance of negative serum 9450-06, as % of positive serum |
< 10 % |
4 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.115 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bâtiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|